TickerFacts.

China Pharma Holdings, Inc. (CPHI): Cash & Equivalents

Annual figures by period end, from SEC filings.

$345.1K
As of 2025-12-31
$304.9K
As of 2026-06-30
-44.6%
3-year compound annual growth
-18.5%
5-year compound annual growth
$4.86M2010-12-31: $3.69M2011-12-31: $4.05M2012-12-31: $4.03M2016-12-31: $2.67M2017-12-31: $2.03M2018-12-31: $1.19M2019-12-31: $1.07M2020-12-31: $957.7K2021-12-31: $4.86M2022-12-31: $2.03M2023-12-31: $1.42M2024-12-31: $626.9K2025-12-31: $345.1K$345.1K
2010-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$345.1K-44.9%2026-04-01, Balance as of period end
2024-12-31$626.9K-56.0%2026-04-01, Balance as of period end
2023-12-31$1.42M-29.9%2024-04-01, Balance as of period end
2022-12-31$2.03M-58.2%2024-04-01, Balance as of period end
2021-12-31$4.86M+407.4%2023-03-30, Balance as of period end
2020-12-31$957.7K-10.9%2022-03-30, Balance as of period end
2019-12-31$1.07M-9.4%2021-03-26, Balance as of period end
2018-12-31$1.19M-41.6%2020-03-30, Balance as of period end
2017-12-31$2.03M-23.8%2019-03-28, Balance as of period end
2016-12-31$2.67Mn/a2018-04-02, Balance as of period end
No annual figure between 2012-12-31 and 2016-12-31.
2012-12-31$4.03M-0.5%2013-03-14, Balance as of period end
2011-12-31$4.05M+9.7%2013-03-14, Balance as of period end
2010-12-31$3.69Mn/a2012-03-14, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
China Pharma Holdings, Inc. (CPHI)2025-12-31$345.1K-44.9%
CervoMed Inc. (CRVO)2025-12-31$8.24M-8.5%
ProPhase Labs, Inc. (PRPH)2025-12-31$90.0K-86.7%
Marker Therapeutics, Inc. (MRKR)2025-12-31$16.07M-16.3%
Camp4 Therapeutics Corp (CAMP)2025-12-31$109.52M+71.0%
Ensysce Biosciences, Inc. (ENSC)2025-12-31$4.31M+23.1%
TherapeuticsMD, Inc. (TXMD)2024-12-31$5.06M+16.9%
Upstream Bio, Inc. (UPB)2025-12-31$101.58M-68.8%
Cartesian Therapeutics, Inc. (RNAC)2025-12-31$125.14M-41.1%

Compare CPHI, CRVO, PRPH, MRKR side by side · Screen every company in Pharmaceutical Preparations ↗